MarketResearchFuture.com adds “Leuprolide Acetate Market – 2018 Global Analysis, Growth, Trends and Opportunities Research Report forecasting to 2023” reports to its database.
Global Leuprolide Acetate Market – Overview:
Leuprolide is a synthetic nonapeptide acetate salt and is analogous to the gonadotropin-releasing hormone. The salt shows a therapeutic effect by binding to the receptors of the gonadotropin-releasing hormone. Leuprolide acetate is widely used as a therapeutic agent for the treatment of prostate cancer in men and precocious and uterine fibroids in women. Upset stomach, breast swelling, vaginal bleeding, impotence, and others are some of the major side effects associated with the use of this salt. The increasing prevalence of prostate cancer and the uterine fibroid is expected to be a major driver for the market growth during the forecast period. In 2015, according to the World Cancer Research Fund International, approximately 1.1 million cases of prostate cancer were recorded in 2014, accounting for ~8% of all the new cancer cases. Moreover, according to a study published in the BMC Women’s Health Journal in 2012, the self-reported prevalence of uterine fibroids was estimated to range from 4.5% in the U.K to 9.8% in Italy. Additionally, the increasing geriatric population and growing pharmaceutical and healthcare sectors boost the market growth. According to the Population Reference Bureau in 2016, the Americas geriatric population is estimated to be more than double and reach about 98 million by 2060. However, factors such as low per capita healthcare expenditure, stringent government policies, and the presence of alternative treatments in the market are likely to restrain the market growth during the forecast period.
The key players in the global leuprolide acetate market are TOLMAR Pharmaceuticals, Inc. (U.S.)
Varian Pharmed (Iran), avenit AG (Switzerland), Takeda Pharmaceutical Company Limited (Japan), Sun Pharmaceutical Industries Ltd. (India), Livzon Pharmaceutical Group Co., Ltd. (China), Beijing Biote Pharmaceutical Co., Ltd (China), Soho-YImIng (China), AbbVie Inc. (U.S.), Sanofi (France), Astellas Pharma (Japan), Abbott (U.S), Merck KGaA (Germany), Pfizer Inc. (U.S.), and others.
Global Leuprolide Acetate Market:
You can get easy access to sample report here, please click: https://www.marketresearchfuture.com/sample_request/785 .
Global Leuprolide Acetate Market – Competitive Analysis:
Characterized by the presence of several well-established and small players, the global market of leuprolide acetate appears to be highly competitive and fragmented. With well-established market in the North America and European region with major companies having their home in the regions and generating maximum market share. These companies have expanded their operating unit in various other emerging regions as well. Moreover the other small and medium scale players are generating revenue from local market.
With top selling cancer products, Takeda and AbbVie account for the major market share for the leuprolide acetate market across the globe. Although there are various other companies involved in the development of the product. Myovant Sciences a Switzerland based company involved in the development of new drug that may be able to cure both women’s health disorders and prostate cancer. Myovant with its new product relugolix has a diverse mechanism of action that that of AbbVie’s Lupron Depot, letting it work faster, while the therapy is presently in last-stage of its development, with data predicted in 2019.
The global leuprolide acetate market is segmented on the basis of application, mode of administration, and end-user.
On the basis of application, the market is segmented into prostate cancer, precocious, uterine fibroid, and others. On the basis of the mode of administration, the market is categorized into intramuscular and subcutaneous. On the basis of end-user, the market is segmented into hospitals, clinics, medical institutes, and others.
Figure 1- Global Leuprolide Acetate Market Share, by Region:
Any query or specific requirement? Ask to our industry expert, please click: https://www.marketresearchfuture.com/enquiry/785 .
Global Leuprolide Acetate Market – Regional Analysis:
The global market is segmented into the various regions including North America, Europe, Asia Pacific, and the Middle East & Africa.
North America accounted for the largest market share. The major factor influencing the growth of the market include increasing aging population that is key factor which will drive the demand for leuprolide acetate market in this region. Furthermore, huge investment in Research and development and advancement of new techniques has caused in better care for the patients and understanding for the medical professionals. Increase medical professionals has resulted in demand for better standards and quality end products which will further influence the demand in the leuprolide acetate market in the North American region.
Europe accounted for the second largest market share for global leuprolide acetate market. According study published by World Cancer Research fund, Europe accounted for the largest number of individuals suffering from prone to prostate and breast cancer influencing the European market for leuprolide acetate. Moreover, rising number of cancer patients in the region, and steady growth in the number of medical professionals in significantly contributes to the growth of the European leuprolide market. Adding to this constant focus on novelty and strict government regulations make sure high quality of products delivered to the end users which further influence the growth of European market.
Asia pacific expect to be fastest growing market due to raising of funds for research and development activities, and growing government initiatives for the awareness and preventive cancer. Particularly, India and China are anticipated to be a growing and the fastest growing market due to improvement in healthcare domain and increasing prevalence of cancer related diseases. Many major players seeking opportunity and expand their presence in this region influencing the growth of the market.
The Middle East & Africa holds the least share in the Leuprolide Acetate market due to lack of awareness, less emphasis on research and development activities, and poor medical facilities.
Global Leuprolide Acetate market:
What makes our report unique?
1) An extensive research study on the Global Leuprolide Acetate market, and its entire ecosystem, describes the market trends, drivers, restraints and opportunities of the Leuprolide Acetate market.
2) We provide you the longest possible market segmentation based on type of products, procedures and geography and describe the market share region wise.
3) The report gives a bird eyes view on the competitive landscape which includes mergers and acquisitions, collaborations, market strategies, and new product launches.
…CONTINUED FOR TOC
Feel free to get in touch for discounts and customized details, please click: https://www.marketresearchfuture.com/check-discount/785 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar